Education
About Us
Working with TipRanks
Follow Us
ZimVie Inc (ZIMV)
NASDAQ:ZIMV
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.22Last Year’s EPS
0.08Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 26, 2025
|% Change Since: -28.09%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
ZimVie had a transformative year with significant strategic shifts and financial improvements, particularly in cash flow and EBITDA margins. However, revenue decline and challenges in the implant market, especially in the specialist segment, present ongoing challenges.Company Guidance
During ZimVie's Fourth Quarter 2024 Earnings Conference Call, the company provided several key metrics and insights into their future guidance. For the full year 2024, ZimVie reported total revenues of $449.7 million, a 1.6% decline from the previous year, though the company achieved a 2% growth in their biomaterials portfolio. The fourth quarter saw revenues of $111.5 million, a slight decrease of 1.4%. Despite these declines, ZimVie improved adjusted EBITDA margins by over two percentage points for the year, achieving a total of $60 million, reflecting an 18% increase over the prior year. The company also managed to pay down debt significantly, reducing net debt to approximately $145 million. Looking forward, ZimVie expects 2025 revenues to range from $445 million to $460 million, with an adjusted EBITDA of $65 million to $70 million, and adjusted earnings per share between $0.80 and $0.95, suggesting substantial growth. The company plans to focus on strengthening their commercial team and expanding their product portfolio to drive this projected growth.Transformation into a Pure-Play Dental Company
ZimVie successfully transformed into a pure-play dental company by selling its spine business, allowing it to fully focus on dental implants, biomaterials, and digital dentistry solutions.
Strong Cash Flow and Debt Reduction
Generated over $21 million in operating cash flow in Q4 and used proceeds from the spine business sale to significantly pay down debt.
Improved EBITDA Margins
Adjusted EBITDA margins improved by over two percentage points for the year, with a fourth quarter adjusted EBITDA of $18.4 million, translating to a 16.5% margin.
Growth in Digital Dentistry Portfolio
ZimVie's digital solutions, excluding scanner sales, grew over 10% for the year and over 20% in Q4. The Implant Concierge service grew 14% for the year.
Positive Adjusted Earnings Growth
Adjusted earnings per share for the year increased by 182% from $0.22 to $0.62.
---
ZIMV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ZIMV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 26, 2025 | $13.10 | $12.88 | -1.68% |
| Oct 30, 2024 | $13.70 | $13.76 | +0.44% |
| Aug 01, 2024 | $20.40 | $17.30 | -15.20% |
| May 08, 2024 | $15.38 | $16.97 | +10.34% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does ZimVie Inc (ZIMV) report earnings?
ZimVie Inc (ZIMV) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is ZimVie Inc (ZIMV) earnings time?
ZimVie Inc (ZIMV) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ZIMV EPS forecast?
ZIMV EPS forecast for the fiscal quarter 2025 (Q1) is 0.22.
---